Victoza vs. Bydureon: Which GLP-1 Option Is Right for You?

Type 2 diabetes can be difficult to manage, especially when standard treatments aren't enough. Victoza and Bydureon are two injectable non-insulin medications that belong to the same class—GLP-1 receptor agonists—but they differ in key ways that may influence your choice. What They Share Help improve blood sugar control Used by adults with type 2 diabetes Work by enhancing insulin production and reducing glucagon May assist with weight loss Common side effects include nausea, diarrhea, and headaches Clinical Insights Studies suggest Victoza may offer slightly more blood sugar reduction and weight loss. However, Bydureon users may experience fewer digestive side effects. Your doctor can help you decide which aligns best with your medical profile. As a prescription referral service, BYR helps eligible U.S. patients access medications prescribed by licensed U.S. doctors. We do not work with insurance providers and only accept prescriptions written in English for personal use. If yo...